Wellgistics Health, Inc. (NASDAQ:WGRX – Get Free Report) was the target of a large decline in short interest during the month of December. As of December 31st, there was short interest totaling 695,222 shares, a decline of 19.7% from the December 15th total of 865,399 shares. Currently, 1.4% of the shares of the stock are short sold. Based on an average trading volume of 442,337 shares, the days-to-cover ratio is currently 1.6 days. Based on an average trading volume of 442,337 shares, the days-to-cover ratio is currently 1.6 days. Currently, 1.4% of the shares of the stock are short sold.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Wellgistics Health in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Check Out Our Latest Report on Wellgistics Health
Wellgistics Health Trading Down 0.6%
Institutional Investors Weigh In On Wellgistics Health
Several hedge funds have recently bought and sold shares of WGRX. ORG Wealth Partners LLC purchased a new position in Wellgistics Health during the 3rd quarter valued at about $89,000. Raymond James Financial Inc. grew its position in Wellgistics Health by 593.8% during the third quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock valued at $52,000 after purchasing an additional 50,000 shares in the last quarter. Finally, Heights Capital Management Inc. acquired a new position in Wellgistics Health in the 3rd quarter valued at approximately $2,588,000.
About Wellgistics Health
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
See Also
- Five stocks we like better than Wellgistics Health
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.
